Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
무증상 COVID-19: SARS-CoV-2에 대한 효율적인 항바이러스 면역으로 질병 내성
Article
[키워드] accompanied
addition
antibodies
Asymptomatic
Asymptomatic case
Asymptomatic cases
asymptomatic patient
asymptomatic patients
CD169
Cell
cellular
characterized
COVID‐19
COVID‐19 patient
COVID‐19
cytokine
Cytokines
disease
Disease progression
disease tolerance
elicit
expressing
gene signatures
growth factor
Growth factors
highlight
identify
immune pathway
Immune phenotype
immune response
immune responses
Immunity
immunology
Inflammatory response
insight
less
limit
mechanism
Microbiology, Virology & Host Pathogen Interaction
monocyte
Monocytes
neutralization capacity
neutralizing antibody
neutrophil
Neutrophils
Peripheral blood
prevent disease progression
progression
proportion
protective immune response
protective mechanisms
responses
robust
SARS‐CoV‐2
SARS‐CoV‐2 infection
SARS‐CoV‐2
Symptom
Symptomatic patients
systemic
systemic level
Th17 cell
Th2
therapeutic target
therapeutic targets
Tolerance
transcriptomic profiles
[DOI] 10.15252/emmm.202114045 PMC 바로가기 [Article Type] Article
[DOI] 10.15252/emmm.202114045 PMC 바로가기 [Article Type] Article